Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ECOG PS 2 Points”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableUnknownNCT05497076
What this trial is testing

The Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer Confirmed by Histopathology or CytologyThe TNM (8th) Phase is IVWith EGFR Mutations+4 more
Fujian Cancer Hospital 9
Not applicableLooking for participantsNCT07239661
What this trial is testing

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerElectroacupuncturePD-1 Inhibitors+1 more
Kong Fanming 120
Early research (Phase 1)UnknownNCT05965102
What this trial is testing

Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 31